Clinical trial
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
NCT00476216 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00476216 |
|---|---|
| Title | Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer |
| Official title | Phase I Feasibility Study of the Combination of Fondaparinux (Arixtra) With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer, Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | Combination of Arixtra with chemotherapy |
| Enrollment | 23 |
| Start date | Sep 1, 2007 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2013 |
| First posted | May 21, 2007 |
| Last update posted | Mar 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: